Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 6.28
-0.16 (-2.48%)
Jun 11, 2026, 3:00 PM CST
SHA:605199 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -340.68 | -287.37 | -274.46 | 10.85 | 85.68 | 72.14 |
Depreciation & Amortization | 98.73 | 98.73 | 77.82 | 58.88 | 51.03 | 48.17 |
Other Amortization | 2.68 | 2.68 | 1.63 | 0.83 | 0.54 | 0.31 |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | -0.04 | 0.08 | 0.01 | 0.09 |
Asset Writedown & Restructuring Costs | 12.74 | 12.74 | 0.86 | - | 0.54 | 1.83 |
Loss (Gain) From Sale of Investments | 2.95 | 2.95 | -8.18 | -0.35 | -0.55 | -0.32 |
Provision & Write-off of Bad Debts | 23.58 | 23.58 | 4.09 | 15.58 | -0.23 | 3.23 |
Other Operating Activities | 278.63 | 64.82 | 44.43 | 33.35 | 22.89 | 12.65 |
Change in Accounts Receivable | -50.56 | -50.56 | 17.8 | -63.98 | -245.05 | -34.15 |
Change in Inventory | 163.83 | 163.83 | -173.06 | -74.9 | -6.06 | -28.79 |
Change in Accounts Payable | 102.74 | 102.74 | 165.42 | 48.19 | 326.9 | 20.38 |
Change in Other Net Operating Assets | -0.08 | -0.08 | - | - | - | - |
Operating Cash Flow | 297.36 | 136.85 | -149.12 | 28.25 | 238.71 | 102.48 |
Operating Cash Flow Growth | - | - | - | -88.17% | 132.93% | 3005.68% |
Capital Expenditures | -52.07 | -83.67 | -156.23 | -489.2 | -392.32 | -137.62 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.07 | 0.08 | 0.26 | 0.11 |
Cash Acquisitions | - | - | - | -35.1 | - | - |
Divestitures | - | - | 13.68 | - | - | - |
Investment in Securities | - | - | - | - | -19.54 | 0.11 |
Investing Cash Flow | -52.07 | -83.66 | -142.48 | -524.21 | -411.6 | -117.1 |
Long-Term Debt Issued | - | 592.9 | 735.74 | 1,140 | 686.02 | 464.22 |
Long-Term Debt Repaid | - | -800.59 | -620.52 | -552.39 | -507.52 | -260.53 |
Net Debt Issued (Repaid) | -233.83 | -207.69 | 115.22 | 588.08 | 178.5 | 203.68 |
Common Dividends Paid | -31.62 | -33.55 | -92.16 | -31.56 | -14.35 | -73.75 |
Other Financing Activities | -50.93 | - | -1.23 | -3.47 | - | 16.38 |
Financing Cash Flow | -316.38 | -241.25 | 21.83 | 553.06 | 164.15 | 146.32 |
Net Cash Flow | -71.09 | -188.05 | -269.77 | 57.1 | -8.74 | 131.7 |
Free Cash Flow | 245.29 | 53.18 | -305.35 | -460.95 | -153.61 | -35.14 |
Free Cash Flow Margin | 34.54% | 5.90% | -21.60% | -25.68% | -10.14% | -2.60% |
Free Cash Flow Per Share | 0.61 | 0.13 | -0.77 | -1.27 | -0.38 | -0.09 |
Cash Income Tax Paid | 50.52 | 91.14 | 147.75 | 133.28 | 138.47 | 124.58 |
Levered Free Cash Flow | 283.76 | 97.51 | -188.22 | -516.59 | -206.31 | -52.48 |
Unlevered Free Cash Flow | 308.56 | 122.97 | -168.37 | -505.19 | -195.06 | -43.81 |
Change in Working Capital | 218.67 | 218.67 | 4.73 | -90.98 | 78.81 | -35.62 |